Earnings Releases·Oct 27, 2026, 7:17 AM ET

HCA Healthcare — Third Quarter 2026 Earnings Summary

Revenues rose 3.6% year-over-year to $19.849 billion, while net income declined 3.9% to $1.579 billion ($7.27 per diluted share); adjusted EBITDA increased 1.2% to $3.918 billion with a margin of 19.7%.
Full-year 2026 guidance was updated to the upper half of previous ranges, forecasting revenues of $77.0–$79.5 billion, net income of $6.3–$6.7 billion, and adjusted EBITDA of $15.4–$16.1 billion.
A significant payer mix shift toward uninsured volume negatively impacted pre-tax income by approximately $400 million, though same facility equivalent admissions grew 3.0% and operating costs improved.
The company returned $2.970 billion to shareholders via $2.970 billion in share repurchases (7.230 million shares) and declared a quarterly dividend of $0.78 per share.
Total debt stood at $50.493 billion with $908 million in cash, while the company operates 189 hospitals and 2,600 ambulatory sites across 19 states and the UK.